| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 66.95B | 67.54B | 65.02B | 58.06B | 45.82B | 40.15B |
| Gross Profit | 15.63B | 16.40B | 16.37B | 13.16B | 8.47B | 6.16B |
| EBITDA | 26.71B | 27.89B | 28.68B | 25.40B | 19.47B | 14.85B |
| Net Income | 4.80B | 2.81B | 5.19B | 6.44B | 3.28B | 1.25B |
Balance Sheet | ||||||
| Total Assets | 279.92B | 293.28B | 276.46B | 274.95B | 237.57B | 205.10B |
| Cash, Cash Equivalents and Short-Term Investments | 56.08B | 48.22B | 38.31B | 27.57B | 23.66B | 21.12B |
| Total Debt | 151.29B | 165.70B | 167.38B | 181.19B | 173.73B | 153.29B |
| Total Liabilities | 186.56B | 202.06B | 195.04B | 206.51B | 190.19B | 166.36B |
| Stockholders Equity | 48.72B | 47.76B | 42.77B | 35.33B | 23.97B | 19.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 20.93B | 18.13B | -2.02B | -17.87B | -36.80B |
| Operating Cash Flow | 0.00 | 30.20B | 27.95B | 26.38B | 19.90B | 13.14B |
| Investing Cash Flow | 0.00 | -6.75B | 8.49B | -18.42B | -31.48B | -40.57B |
| Financing Cash Flow | 0.00 | -13.51B | -24.60B | -5.46B | 12.03B | 29.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥49.97B | 3.58 | ― | 0.79% | -1.67% | 18.47% | |
80 Outperform | ¥14.05B | 8.60 | ― | 3.04% | 4.45% | 29.58% | |
74 Outperform | ¥153.03B | 9.98 | ― | 3.65% | 7.73% | -19.90% | |
73 Outperform | ¥78.14B | 6.51 | ― | 3.48% | 4.17% | 24.54% | |
73 Outperform | ¥14.77B | 7.26 | ― | 3.85% | 4.96% | 38.47% | |
68 Neutral | ¥76.28B | 9.20 | ― | 3.63% | 2.67% | 18.02% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |